NGUYEN PHUOC LONG

I am a young scientific enthusiast in modern biomedicine. I graduated from University of Medicine and Pharmacy at Ho Chi Minh City as an M.D. (2015) and I am currently a Ph.D. candidate at College of Pharmacy, Seoul National University (2016 - now).

During my undergraduate period, I selectively focused on studying molecular cell biology, biochemistry, and bio-statistics.

My current research focuses on the applications of multi-omics platforms and machine learning in biomarker discovery and validation. In the near future, I wish to apply panomics (also known as multi-omics) to facilitate the development of precision medicine, particularly diagnostic accuracy and patient management. I also have a keen interest in finding the mechanisms of various diseases, especially cancers and neurological disorders.

Besides, I have developed and optimized mass spectrometry-based metabolomics and lipidomics methods for the analysis of various biomedical matrices.

My full CV can be found here.

Update 09 July 2018 (started from late 2016):

Being involved in fascinating projects that utilize multi-omics data analysis to get better insights into the pathobiology of various cancers and neurological diseases.

  • A manuscript about X-linked adrenoleukodystrophy is about to be submitted (31 July 2018).
  • A manuscript about breast cancer had been submitted (20 July 2018).

Update 02 July 2018:

Small achievement of the year: h-index of 5 (Google Scholar).

Update 01 June 2018:

I am getting my very first steps on RNA-seq data management, manipulation, and analysis. Exciting! Big thanks to all of the giants of this field!

  • Have done a full NGS analysis pipeline for a simple sample (25 July 2018).

Update 23 May 2018:

A mixed background in biomedicine, omics science, data science, and biochemical analysis has given me an unique opportunity to work in various fields of biomedical sciences. In the near future, I would like to extend my capability to fit the requirements of the multi-omics integration approach for precision medicine in oncology and neurology.

Update 07 April 2017:

Welcome to the world, my lovely daughter!